These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6178495)

  • 1. Single agent palliative chemotherapy for end-stage Hodgkin's disease.
    Mead GM; Harker WG; Kushlan P; Rosenberg SA
    Cancer; 1982 Sep; 50(5):829-35. PubMed ID: 6178495
    [No Abstract]   [Full Text] [Related]  

  • 2. The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study.
    Hansen HH; Selawry OS; Pajak TF; Spurr CL; Falkson G; Brunner K; Cuttner J; Nissen NI; Holland JF
    Cancer; 1981 Jan; 47(1):14-8. PubMed ID: 7006789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lomustine (CeeNU).
    Med Lett Drugs Ther; 1976 Nov; 18(24):102-3. PubMed ID: 995062
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin's disease, lymphosarcoma nad reticulum cell sarcoma.
    Maurice P; Glidewell O; Jacquillat C; Silver RT; Carey R; Pas AT; Cornell CJ; Burningham RA; Nissen NI; Holland JF
    Cancer; 1978 May; 41(5):1658-63. PubMed ID: 348294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleomycin (NSC-125066) and CCNU (NSC-79037) in the combination chemotherapy of mopp-resistant hodgkin's disease.
    Kurnick JE; White M; Ware DE; Robinson WA
    Cancer Chemother Rep; 1975; 59(6):1147-50. PubMed ID: 56989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease.
    Diggs CH; Wiernik PH; Levi JA; Kvols LK
    Cancer; 1977 May; 39(5):1949-54. PubMed ID: 870162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of advanced Hodgkin's disease with B-CAVE following MOPP failure.
    Porzig KJ; Portlock CS; Robertson A; Rosenberg SA
    Cancer; 1978 May; 41(5):1670-5. PubMed ID: 77180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-fluorouracil versus CCNU in the treatment of metastatic prostatic cancer.
    Tejada F; Eisenberger MA; Broder LA; Cohen MH; Simon R
    Cancer Treat Rep; 1977 Nov; 61(8):1589-90. PubMed ID: 922761
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4].
    Brunner KW; Maurice P; Sonntag RW
    Schweiz Med Wochenschr; 1972 Oct; 102(43):1546-51. PubMed ID: 4647016
    [No Abstract]   [Full Text] [Related]  

  • 10. [N-nitrosomethylurea in the chemotherapy of lymphogranulomatosis].
    Vermel' AE; Korman NP; Magagina GE; Raevskiĭ IG
    Vopr Onkol; 1974; 20(3):8-13. PubMed ID: 4439805
    [No Abstract]   [Full Text] [Related]  

  • 11. A clinical trial of CCNU (1-(2 chloroethyl)-3-cyclohexyl-1-nitrosourea) (NSC 79037) in advanced ovarian carcinoma.
    Sasaki TM; McConnell DB; Moseley HS; Merhoff GC; Fletcher WS
    J Surg Oncol; 1975; 7(5):347-50. PubMed ID: 1100915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Southeastern Cancer Study Group trials with nitrosoureas in Hodgkin's disease.
    Durant JR; Bartolucci A; Gams RA; Dorfman RF; Velez-Garcia E
    Cancer Treat Rep; 1976 Jun; 60(6):781-7. PubMed ID: 782700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of two chemotherapy protocols in Hodgkin's disease.
    Pavlovsky S; Morgenfeld M; Somoza N; Magnasco J; Sackmann Muriel F; Cavagnaro F; Suárez A; Barros CA; Saslavsky J; Garay G; Palau M; Besuschio SC
    Medicina (B Aires); 1981; 41 Suppl():15-21. PubMed ID: 6896551
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU.
    Young RC; DeVita VT; Serpick AA; Canellos GP
    N Engl J Med; 1971 Aug; 285(9):475-9. PubMed ID: 5558887
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination chemotherapy with CCNU (NSC-79037) and 5-(3, 3-bis(2-chloroethyl)-1-triazeno)-imidazole-4-carboxamide (NSC-82196).
    Chang H; Freireich EJ; Khaliq A; Einhorn L; Gottlieb JA
    Cancer Chemother Rep; 1975; 59(4):769-71. PubMed ID: 1100230
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination chemotherapy with VM 26 and CCNU in primary malignant brain tumors.
    Seiler RW; Vassella F; Markwalder H
    Surg Neurol; 1979 Mar; 11(3):237-42. PubMed ID: 473022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage chemotherapy for non-Hodgkin's lymphoma.
    Ng PR; Todd D; Khoo RK
    Cancer Treat Rep; 1982 Nov; 66(11):1977-9. PubMed ID: 7139640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.
    Stolinsky DC; Bull FE; Pajak TF; Bateman JR
    Oncology; 1975; 31(5-6):288-92. PubMed ID: 174040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of advanced stage Hodgkin disease with CCNU, etoposide and prednimustine (CEP)].
    Illés A; Bányai A; Szegedi G
    Orv Hetil; 1994 May; 135(22):1187-90. PubMed ID: 8015814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results with CCNU in resistant Hodgkin's and non-Hodgkin's lymphoma.
    Stolinsky DC; Solomon J; Weiner JM; Bateman JR
    Oncology; 1976; 33(5-6):271-3. PubMed ID: 800240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.